← Back to home

MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA

Clinical trials for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1

New study investigates brain fog after Cutting-Edge cancer treatments

Knowledge-focused Not yet recruiting

This study looks at whether newer immunotherapies for blood cancers, like CAR-T cells and bispecific antibodies, can cause long-term problems with memory, attention, and thinking. Researchers will test 225 patients in Denmark using standard cognitive tests and surveys. The goal i…

Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA

Sponsor: Aarhus University Hospital • Aim: Knowledge-focused

Last updated May 11, 2026 20:39 UTC

MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA

Get alerted when new MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA trials appear

New study investigates brain fog after Cutting-Edge cancer treatments